Effect of a 15-day Memantine Treatment on Biomarkers of AD in Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 25 May 2017
At a glance
- Drugs Memantine (Primary)
- Indications Alzheimer's disease
- Focus Biomarker; Pharmacodynamics
- 25 Oct 2016 Status changed from not yet recruiting to recruiting.
- 12 May 2016 Planned End Date changed from 1 Feb 2016 to 1 Feb 2018.
- 12 May 2016 Planned primary completion date changed from 31 Jan 2016 to 1 Jan 2018.